PL EN

Aktualności

GMP: Frequently asked GMP Question: How to reduce testing and comply with GMP?

22.08.2013
Testing active pharmaceutical ingredients, excipients and packaging materials is one of the main tasks of the quality control units in the pharmaceutical industry. It must be ensured that the ...

GMP: Interesting APIC/CEFIC Guideline for the Qualification of Contract Laboratories

22.08.2013
The guideline is supposed to define uniform requirements for the \"life cycle management\" of contract laboratories. In addition the APIC had already prepared a guideline for the management of ...

GMP: What\'s new from the FDA regarding Medical Devices?

22.08.2013
In hardly any other area the FDA ‘s Center for Devices and Radiological Health publishes so many guidelines as in the area of medical devices. This is a consequence of the wide range of medical ...

GMP: New EMA Guideline on Starting Materials from Biological Medicinal Products

22.08.2013
The Guideline describes the requirements for the quality documentation of module 3 of the marketing authorisation dossier. Here, the complete manufacturing process including all sources as well as ...

EMA: Draft guideline on clinical investigation of medicinal products for the treatment of amyotrophic lateral sclerosis

08.08.2013
This document replaces and updates the previous points to consider on amyotrophic lateral sclerosis and focuses on the design of studies for disease-modifying as well as symptomatic treatments in ...

EMA: Concept paper on the development of product-specific guidance on demonstration of bioequivalence

08.08.2013
This document describes for specific products the regulatory view on specific aspects related to the demonstration of bioequivalence based on previous assessments of generic medicines. ...

EMA: Guideline on pharmaceutical development of medicines for paediatric use

08.08.2013
The “Paediatric Regulation” aims to facilitate the development and accessibility of age-appropriate paediatric medicines. This aim should be achieved without subjecting children to unnecessary ...

EMA: Reflection paper on management of clinical risks deriving from insertional mutagenesis

08.08.2013
This reflection paper is aimed at discussing the factors contributing to genotoxicity of vector integration, the strategies to reduce the risk associated to insertional mutagenesis and the assays ...

EMA: Guideline on the requirements for combined vaccines and associations of immunological veterinary medicinal products (IVMPs)

01.08.2013
This document provides guidance on the data requirements to support authorisation of combined vaccines and a claim for the use of two or more IVMPs, each with its own separate marketing ...

GMP: New EMA Inspection Requirements on Good Distribution Practices (GDP)

01.08.2013
On 27 June 2013, the EU Commission updated the so-called \"Compilation of Community Procedures on Inspections and Exchange of Information\". This document serves the exchange of information and ...

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny